| __timestamp | ACADIA Pharmaceuticals Inc. | Bausch Health Companies Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 246000000 |
| Thursday, January 1, 2015 | 73869000 | 582800000 |
| Friday, January 1, 2016 | 99284000 | 455000000 |
| Sunday, January 1, 2017 | 149189000 | 366000000 |
| Monday, January 1, 2018 | 187163000 | 414000000 |
| Tuesday, January 1, 2019 | 240385000 | 471000000 |
| Wednesday, January 1, 2020 | 319130000 | 452000000 |
| Friday, January 1, 2021 | 239415000 | 465000000 |
| Saturday, January 1, 2022 | 361575000 | 529000000 |
| Sunday, January 1, 2023 | 351619000 | 604000000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, ACADIA's R&D expenses surged by nearly 480%, peaking in 2022. This reflects their aggressive pursuit of groundbreaking therapies. Meanwhile, Bausch Health's R&D spending, although more stable, saw a notable 145% increase, reaching its zenith in 2023. This steady growth underscores their commitment to enhancing existing product lines. The data reveals a fascinating narrative of how these companies allocate resources to fuel future growth. As the pharmaceutical landscape evolves, understanding these trends offers valuable insights into the strategic priorities of industry leaders.
R&D Spending Showdown: Novartis AG vs ACADIA Pharmaceuticals Inc.
Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Analyzing R&D Budgets: Ionis Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Mesoblast Limited
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated